Marshall Wace’s Dogwood Therapeutics DWTX Stock Holding History

Marshall Wace’s Portfolio DWTX Stock Details DWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,756	Closed	-$24.8K	–	3854
2026 Q1	$24.8K	Buy	11,756 +101	+0.9%	+$297	﹤0.01%	3035
2025 Q4	$48.5K	Buy	+11,655	New	+$68.6K	﹤0.01%	2780

Other funds holding DWTX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace's DWTX Position: Q2 2026 in Review

Marshall Wace sold out of Dogwood Therapeutics (DWTX) in Q2 2026, closing a stake of 11,756 shares — an estimated $24.8K sold.

Marshall Wace first reported a position in DWTX in Q4 2025 and held it in 2 quarters. The position peaked at $48.5K in Q4 2025. 15 funds tracked by Wall St. Rank hold DWTX as of Q2 2026.

Marshall Wace reported no remaining Dogwood Therapeutics position as of Q2 2026 after selling out during the quarter.
Marshall Wace sold 11,756 Dogwood Therapeutics shares in Q2 2026, an estimated $24.8K.
Marshall Wace first reported a position in Dogwood Therapeutics in Q4 2025 and held it in 2 quarters.
Marshall Wace's Dogwood Therapeutics position peaked at $48.5K in Q4 2025.
15 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.